UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment

Diagnostics (Basel), 2022-02, Vol.12 (2), p.388

2022

Volltextzugriff (PDF)

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

Journal of clinical oncology, 2006-04, Vol.24 (11), p.1705-1711

2006

Volltextzugriff (PDF)

Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

Cancer imaging, 2020-08, Vol.20 (1), p.1-58, Article 58

2020

Volltextzugriff (PDF)

Fluorinated tracers for imaging cancer with positron emission tomography

European journal of nuclear medicine and molecular imaging, 2004-08, Vol.31 (8), p.1182-1206

2004

Volltextzugriff (PDF)

18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer

Clinical nuclear medicine, 2018-12, Vol.43 (12), p.e471-e472

2018

Volltextzugriff (PDF)

Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France

Journal of Nuclear Medicine, 2015-08, Vol.56 (8), p.1212-1217

2015

Volltextzugriff (PDF)

Development and Validation of Analytical Methods for Radiochemical Purity of 177Lu-PSMA-1

Pharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (5), p.522

2022

Volltextzugriff (PDF)

Reduction of renal uptake of 111In‐DOTA‐labeled and A700‐labeled RAFT‐RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging

Cancer science, 2012-06, Vol.103 (6), p.1105-1110

2012

Volltextzugriff (PDF)

Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy

Nephrology, dialysis, transplantation, 2009-08, Vol.24 (8), p.2598-2600

2009

Volltextzugriff (PDF)

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement

Journal of Nuclear Medicine, 2012-08, Vol.53 (8), p.1185-1192

2012

Volltextzugriff (PDF)

Nuclear medicine training and practice in France

European journal of nuclear medicine and molecular imaging, 2013-06, Vol.40 (6), p.976-978

2013

Volltextzugriff (PDF)

Study of inter- and intra-observer reproducibility in the interpretation of [18F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment

EJNMMI research, 2014-05, Vol.4 (1), p.25-25, Article 25

2014

Volltextzugriff (PDF)

The impacts of blended learning design in first year medical studies

Studies in health technology and informatics, 2015-01, Vol.210, p.607

2015

Volltextzugriff (PDF)

Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy

The journal of clinical endocrinology and metabolism, 2007-12, Vol.92 (12), p.4590-4597

2007

Volltextzugriff (PDF)

F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma

European journal of nuclear medicine and molecular imaging, 2014-08, Vol.41 (8), p.1501-1510

2014

Volltextzugriff (PDF)

Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices

Annales d'endocrinologie, 2014-09, Vol.75 (4), p.241-246

2014

Volltextzugriff (PDF)

FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union

Brazilian Archives of Biology and Technology, 2007-09, Vol.50 (spe), p.77-90

2007

Volltextzugriff (PDF)

Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

European journal of nuclear medicine and molecular imaging, 2009-05, Vol.36 (5), p.758-764

2009

Volltextzugriff (PDF)

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years

Annals of nuclear medicine, 2017-06, Vol.31 (5), p.379-389

2017

Volltextzugriff (PDF)

Technétium : un risque de pénurie inquiétant pour la santé publique

Bulletin de l'Académie nationale de médecine, 2014-02, Vol.198 (2), p.365-368

2014

Volltextzugriff (PDF)

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

Nuclear medicine communications, 2011-02, Vol.32 (2), p.91-97

2011

Volltextzugriff (PDF)

Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model

Cancer biotherapy & radiopharmaceuticals, 2008-12, Vol.23 (6), p.691

2008

Volltextzugriff (PDF)

Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial

Clinical cancer research, 2003-09, Vol.9 (10 Pt 2), p.3973S

2003

Volltextzugriff (PDF)

L'imagerie oncologique et les règles internationales de l'évaluation: l'imagerie nucléaire

Bulletin du cancer, 2009-11, Vol.96 (11), p.1127-1137

2009

Volltextzugriff (PDF)

Radioimmunotherapy in Medullary Thyroid Cancer Using Bispecific Antibody and Iodine 131-labeled Bivalent Hapten: Preliminary Results of a Phase I/II Clinical Trial

Clinical cancer research, 1999-10, Vol.5 (10), p.3190s

1999

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(38)
Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Female
(26)
Male
(22)
Aged
(19)
Middle Aged
(19)
Life Sciences
(18)
Adult
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Oncology
(15)
Radiology, Nuclear Medicine & Medical Imaging
(14)
Radiopharmaceuticals
(11)
Aged, 80 And Over
(10)
Nuclear Medicine
(10)
Cancer
(9)
Animals
(8)
Treatment Outcome
(8)
Medicine
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

Fluorinated tracers for imaging cancer with positron emission tomography

18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer

Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France

Development and Validation of Analytical Methods for Radiochemical Purity of 177Lu-PSMA-1

Reduction of renal uptake of 111In‐DOTA‐labeled and A700‐labeled RAFT‐RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging

Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement

Nuclear medicine training and practice in France

Study of inter- and intra-observer reproducibility in the interpretation of [18F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment

The impacts of blended learning design in first year medical studies

Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy

F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma

Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices

FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union

Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years

Technétium : un risque de pénurie inquiétant pour la santé publique

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model

Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial

L'imagerie oncologique et les règles internationales de l'évaluation: l'imagerie nucléaire

Radioimmunotherapy in Medullary Thyroid Cancer Using Bispecific Antibody and Iodine 131-labeled Bivalent Hapten: Preliminary Results of a Phase I/II Clinical Trial

Suchergebnisse filtern